Reporting of Harm in Randomized Controlled Trials Published in the Urological Literature
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
PURPOSE: Evidence-based decision making seeks to balance potential benefits and harms (adverse effects) of health care interventions for an individual patient. We determined the prevalence and completeness of harm reporting in randomized controlled trials in the urological literature. MATERIALS AND METHODS: We performed a systematic literature search of all randomized controlled trials of therapeutic interventions published in The Journal of Urology, Urology, European Urology and BJU International in 1996 and 2004. Each article was reviewed by 2 independent investigators for 10 harm reporting criteria recommended by the CONSORT group. Discrepancies were settled by discussion and consensus. RESULTS: A total of 152 randomized controlled trials met the inclusion criteria, of which 109 (72%) reported adverse event outcomes. The median number of harm reporting criteria satisfied improved marginally from 1996 to 2004 (2.8 to 3.3, p = 0.36). A large proportion of studies failed to address harm in the abstract (55, 36%), introduction (71, 47%) and discussion (52, 34%). Few studies specified which adverse events were evaluated (21, 14%), when harm information was collected (32, 21%) or how the harm was attributed to the intervention (5, 3%). Only 48 (32%) articles provided reasons for patient withdrawal and 1 in 5 (33, 22%) reported the severity of adverse events. CONCLUSIONS: Randomized controlled trials published in the urological literature contain significant deficiencies in adverse event reporting. These findings suggest the need for reporting standards for harm in urological journals. Improvements in adverse event reporting would permit a more balanced assessment of interventions and would enhance evidence-based urological practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Going from evidence to recommendations
Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39493.646875.ae · Cited by 1,810
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
Chan, A.-W. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041086 · Cited by 444
Availability of large-scale evidence on specific harms from systematic reviews of randomized trials.
Papanikolaou, P. N., & Ioannidis, J. P. A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.026 · Cited by 79
Cited by
Hodkinson, A., Kirkham, J. J., Tudur-Smith, C., & Gamble, C. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003436 · Cited by 111
“3d) 16 (11, 23) 3e) 22 (15, 29) 10 (0, 45) 16 (10, 23) 59 (49, 69)”
Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events
Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.04.020 · Cited by 109
Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events
Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.04.022 · Cited by 63
Loke, Y. K., Golder, S. P., & Vandenbroucke, J. P. (2011) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098611401129 · Cited by 49
“…to measure rare events, exclusion of patients with risk factors for adverse events, and slicing up of adverse effects data into many subcategories (with few events in each subcategory) [Breau et al. 2010; De Vries and Van Roon, 2010; Pitrou et al. 2009; Loke et al. 2007; Loke and Derry, 2001].”
BackgroundCornelius, V. R., Sauzet, O., Williams, J. E., Ayis, S., Farquhar-Smith, P., Ross, J. R., Branford, R. A., & Peacock, J. L. (2013) · Pain · doi:10.1016/j.pain.2012.08.012 · Cited by 49
“Empirical studies evaluating the reporting of adverse event data in other areas have found it to be substandard [2–4,18,21].”
Background
Metadata
- Authors
- Breau, R. H., Gaboury, I., Scales, C. D., Fesperman, S. F., Watterson, J. D., & Dahm, P.
- Venue
- Journal of Urology
- Published
- 2010-05
- Volume
- 183
- Issue
- 5
- Pages
- 1693-1697
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W1998644444
- Cited by
- 58
- References
- 5
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reporting of Harm in Randomized Controlled Trials Published in the Urological Literature. https://app.cochat.ai/papers/10.1016/j.juro.2010.01.030
- The paper
- Breau, R. H., Gaboury, I., Scales, C. D., Fesperman, S. F., Watterson, J. D., & Dahm, P. (2010). Reporting of Harm in Randomized Controlled Trials Published in the Urological Literature. Journal of Urology. https://doi.org/10.1016/j.juro.2010.01.030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.